Literature DB >> 22975758

Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer.

Claire E Wakefield1, Heather Thorne, Judy Kirk, Eveline Niedermayr, Emma L Doolan, Kathy Tucker.   

Abstract

PURPOSE: The Kathleen Cuningham Foundation Consortium for Research into Familial Aspects of Breast Cancer (kConFab) is a large-scale research study that notifies participants when new, personally relevant, information is discovered. In 2009, the (kConFab) instituted an intensive notification process to ensure at-risk individuals were effectively notified. This study (i) evaluated the impact of intensive notification on genetic testing uptake; (ii) identified those most likely to undergo testing postnotification; and (iii) identified those most likely to acknowledge that they had been notified.
METHODS: Clinical/demographic data were retrieved from the (kConFab) database. Logistic regression analyses were conducted to identify potential predictors of testing uptake and notification acknowledgment using IBM SPSS.
RESULTS: A total of 155 of 1,812 individuals underwent testing after standard notification (8.6%). In comparison, 23/291 individuals (7.9%) notified using the "intensive" approach underwent testing (χ(2) = 0.14; P = 0.71). After controlling for notification process, females and participants with a previous cancer were most likely to have undergone testing (P < 0.006). Older individuals (50+ years) were most likely to acknowledge they had been notified (P = 0.038).
CONCLUSION: Increasing the intensity of participant follow-up did not increase genetic testing uptake. The challenge to effectively notify participants, and increase the proportion whose risk is managed clinically, remains, particularly for males and individuals unaffected by cancer.Genet Med 2013:15(3):187-194.

Entities:  

Mesh:

Year:  2012        PMID: 22975758     DOI: 10.1038/gim.2012.115

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  7 in total

1.  Timing and context: important considerations in the return of genetic results to research participants.

Authors:  Kate A McBride; Nina Hallowell; Martin H N Tattersall; Judy Kirk; Mandy L Ballinger; David M Thomas; Gillian Mitchell; Mary-Anne Young
Journal:  J Community Genet       Date:  2015-05-26

2.  Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.

Authors:  Amanda M Willis; Sian K Smith; Bettina Meiser; Mandy L Ballinger; David M Thomas; Martin Tattersall; Mary-Anne Young
Journal:  J Genet Couns       Date:  2018-02-17       Impact factor: 2.537

3.  Connecting patients, researchers and clinical genetics services: the experiences of participants in the Australian Ovarian Cancer Study (AOCS).

Authors:  Ashley Crook; Loren Plunkett; Laura E Forrest; Nina Hallowell; Samantha Wake; Kathryn Alsop; Margaret Gleeson; David Bowtell; Gillian Mitchell; Mary-Anne Young
Journal:  Eur J Hum Genet       Date:  2014-05-14       Impact factor: 4.246

4.  Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Belinda Rahman; Kathy Tucker; Benjamin Cheah; Adrian Bickerstaffe; John Hopper; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

5.  TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.

Authors:  Rachel Delahunty; Linh Nguyen; Stuart Craig; Belinda Creighton; Dinuka Ariyaratne; Dale W Garsed; Elizabeth Christie; Sian Fereday; Lesley Andrews; Alexandra Lewis; Sharne Limb; Ahwan Pandey; Joy Hendley; Nadia Traficante; Natalia Carvajal; Amanda B Spurdle; Bryony Thompson; Michael T Parsons; Victoria Beshay; Mila Volcheck; Timothy Semple; Richard Lupat; Kenneth Doig; Jiaan Yu; Xiao Qing Chen; Anna Marsh; Christopher Love; Sanela Bilic; Maria Beilin; Cassandra B Nichols; Christina Greer; Yeh Chen Lee; Susan Gerty; Lynette Gill; Emma Newton; Julie Howard; Rachel Williams; Christie Norris; Andrew N Stephens; Erin Tutty; Courtney Smyth; Shona O'Connell; Thomas Jobling; Colin J R Stewart; Adeline Tan; Stephen B Fox; Nicholas Pachter; Jason Li; Jason Ellul; Gisela Mir Arnau; Mary-Anne Young; Louisa Gordon; Laura Forrest; Marion Harris; Karen Livingstone; Jane Hill; Georgia Chenevix-Trench; Paul A Cohen; Penelope M Webb; Michael Friedlander; Paul James; David Bowtell; Kathryn Alsop
Journal:  J Clin Oncol       Date:  2022-03-09       Impact factor: 50.717

6.  Lost in translation: returning germline genetic results in genome-scale cancer research.

Authors:  Amber L Johns; Skye H McKay; Jeremy L Humphris; Mark Pinese; Lorraine A Chantrill; R Scott Mead; Katherine Tucker; Lesley Andrews; Annabel Goodwin; Conrad Leonard; Hilda A High; Katia Nones; Ann-Marie Patch; Neil D Merrett; Nick Pavlakis; Karin S Kassahn; Jaswinder S Samra; David K Miller; David K Chang; Marina Pajic; John V Pearson; Sean M Grimmond; Nicola Waddell; Nikolajs Zeps; Anthony J Gill; Andrew V Biankin
Journal:  Genome Med       Date:  2017-04-28       Impact factor: 11.117

7.  Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast Cancer.

Authors:  Angela R Bradbury; Linda Patrick-Miller; Brian L Egleston; Kara N Maxwell; Laura DiGiovanni; Jamie Brower; Dominique Fetzer; Jill Bennett Gaieski; Amanda Brandt; Danielle McKenna; Jessica Long; Jacquelyn Powers; Jill E Stopfer; Katherine L Nathanson; Susan M Domchek
Journal:  JCO Precis Oncol       Date:  2018-04-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.